Mount Sinai receives $8 million from DataPhilanthropy to accelerate drug discovery for CADASIL and related brain disorders

Previous
Previous

Blood biomarkers may help early detection of Alzheimer’s

Next
Next

Debating on the clinical utility of blood-based biomarkers for Alzheimer diagnosis